Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
improve decrease » improve disease (Expand Search), improved urease (Expand Search)
improves disease » improve disease (Expand Search), graves disease (Expand Search)
Showing 401 - 420 results of 34,143 for search '(( significantly ((improve decrease) OR (improves disease)) ) OR ( significant decrease decrease ))', query time: 0.32s Refine Results
  1. 401
    Socio-demographic characteristics of hypertensive patients’ caregivers (n = 422).

    Socio-demographic characteristics of hypertensive patients’ caregivers (n = 422). by Chikondi Maluwa (20660522)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 402
    Participants enrollment.

    Participants enrollment. by Chikondi Maluwa (20660522)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 403
    Effects of lactoferrin and Coenzyme Q10 on skeletal muscle of mice.

    Effects of lactoferrin and Coenzyme Q10 on skeletal muscle of mice. by Wenbin Wu (292223)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 404
    Each group’s performance on behavioral tests.

    Each group’s performance on behavioral tests. by Wenbin Wu (292223)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 405
    Comparison of knowledge retention among different socio-demographic factors using independent t-test (n = 422).

    Comparison of knowledge retention among different socio-demographic factors using independent t-test (n = 422). by Chikondi Maluwa (20660522)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 406
    Parameters for the treadmill during the testing phase.

    Parameters for the treadmill during the testing phase. by Wenbin Wu (292223)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 407
    Transcriptome sequencing enriched sarcopenia related GO Biological process (BP) and Molecular function (MF). Enriched GO BP of DEGs.

    Transcriptome sequencing enriched sarcopenia related GO Biological process (BP) and Molecular function (MF). Enriched GO BP of DEGs. by Wenbin Wu (292223)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 408
    KAP assessment scores (n = 422).

    KAP assessment scores (n = 422). by Chikondi Maluwa (20660522)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 409
    Pearson correlation test, correlations between KAP and correlations between age and KAP at baseline and six weeks post-health education (n = 422).

    Pearson correlation test, correlations between KAP and correlations between age and KAP at baseline and six weeks post-health education (n = 422). by Chikondi Maluwa (20660522)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 410
    HE staining of the gastrocnemius muscle.

    HE staining of the gastrocnemius muscle. by Wenbin Wu (292223)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 411
    qPCR verified the expression changes of GO and KEGG pathway enriched sarcopenia related DEGs.

    qPCR verified the expression changes of GO and KEGG pathway enriched sarcopenia related DEGs. by Wenbin Wu (292223)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 412
    The reduced virulence of Δalta1 mutants is not primarily due to a decrease in growth.

    The reduced virulence of Δalta1 mutants is not primarily due to a decrease in growth. by Shuhuan Zhang (748003)

    Published 2025
    Save to List
    Saved in:
  13. 413
    The ATR-CHK1 inhibitor AZD6738 decreases HBV cccDNA level.

    The ATR-CHK1 inhibitor AZD6738 decreases HBV cccDNA level. by Kaitao Zhao (3617825)

    Published 2025
    Save to List
    Saved in:
  14. 414
    Annual number of outpatient visits in all eyes.

    Annual number of outpatient visits in all eyes. by Yasuyuki Sotani (20114144)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 415
    Time course of optical coherence tomography and fundus findings in a representative non-recurrent eye.

    Time course of optical coherence tomography and fundus findings in a representative non-recurrent eye. by Yasuyuki Sotani (20114144)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 416
    Time course of central retinal thickness (CRT) in recurrence and non-recurrence groups.

    Time course of central retinal thickness (CRT) in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 417
    Time course of best-corrected visual acuity (BCVA) in all eyes.

    Time course of best-corrected visual acuity (BCVA) in all eyes. by Yasuyuki Sotani (20114144)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 418
    Annual number of outpatient visits in recurrence and non-recurrence groups.

    Annual number of outpatient visits in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 419
    Time course of central retinal thickness (CRT) in all eyes.

    Time course of central retinal thickness (CRT) in all eyes. by Yasuyuki Sotani (20114144)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 420
    Annual treatment frequencies in all eyes.

    Annual treatment frequencies in all eyes. by Yasuyuki Sotani (20114144)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: